Literature DB >> 17614771

Thyroid disease and vascular function.

Penelope J D Owen1, Ramsey Sabit, John H Lazarus.   

Abstract

Altered cardiac function in thyroid disease is well recognized and has been extensively investigated, vascular function has however been less well studied in those with thyroid dysfunction. Thyroid hormones, thyroxine (T(4)) and triiodothyronine (T(3)) are important regulators of cardiac function and cardiovascular hemodynamics. The cardiovascular system responds to minimal but persistent changes in circulating thyroid hormone levels producing changes in vascular reactivity and endothelial function. The detection of endothelial dysfunction and/or arterial stiffness allows early identification of individuals at risk as these occur in both patients with risk factors for coronary artery disease and in those with established disease. This may allow treatment to be targeted at high risk individuals with the aim of slowing the progression of vascular disease. The various methods used to assess arterial function are reviewed and the changes demonstrated in human and animal models of thyroid dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614771     DOI: 10.1089/thy.2007.0051

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  26 in total

1.  Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.

Authors:  Li-Qun Gu; Lin Zhao; Wei Zhu; Feng-Ying Li; Min-Jia Zhang; Yun Liu; Jian-Min Liu; Guang Ning; Yong-Ju Zhao
Journal:  Endocrine       Date:  2011-03-09       Impact factor: 3.633

2.  Severe Cerebral Vasospasm in Patients with Hyperthyroidism.

Authors:  Hyuk-Jin Oh; Seok-Mann Yoon; Jae-Sang Oh; Jai-Joon Shim; Hack-Gun Bae
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2016-12-31

3.  Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes.

Authors:  N Mansournia; S Riyahi; S Tofangchiha; M A Mansournia; M Riahi; Z Heidari; E Hazrati
Journal:  J Endocrinol Invest       Date:  2016-10-13       Impact factor: 4.256

4.  Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.

Authors:  Connie M Rhee; Steven Kim; Daniel L Gillen; Tolga Oztan; Jiaxi Wang; Rajnish Mehrotra; Sooraj Kuttykrishnan; Danh V Nguyen; Steven M Brunelli; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2015-01-29       Impact factor: 5.958

5.  Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese.

Authors:  Ya-Ting Yu; Chih-Te Ho; Hua-Shai Hsu; Chia-Ing Li; Lance E Davidson; Chiu-Shong Liu; Tsai-Chung Li; Chuen-Ming Shih; Cheng-Chieh Lin; Wen-Yuan Lin
Journal:  Endocrine       Date:  2013-03-07       Impact factor: 3.633

6.  Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice.

Authors:  Edoardo Guastamacchia; Vincenzo Triggiani; Alberto Aglialoro; Antimo Aiello; Lucia Ianni; Mauro Maccario; Michele Zini; Carlo Giorda; Rinaldo Guglielmi; Corrado Betterle; Roberto Attanasio; Giorgio Borretta; Piernicola Garofalo; Enrico Papini; Roberto Castello; Antonio Ceriello
Journal:  Endocrine       Date:  2014-11-18       Impact factor: 3.633

Review 7.  The debate on treating subclinical hypothyroidism.

Authors:  Eng Loon Tng
Journal:  Singapore Med J       Date:  2016-10       Impact factor: 1.858

8.  Thyroid hormone receptor-α and vascular function.

Authors:  Ayako Makino; Hong Wang; Brian T Scott; Jason X-J Yuan; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-08       Impact factor: 4.249

9.  Endothelial function is not changed during short-term withdrawal of thyroxine in patients with differentiated thyroid cancer and low cardiovascular risk.

Authors:  Hyuk-Jae Chang; Kyung Won Kim; Sung Hee Choi; Soo Lim; Kyoung Un Park; Do Joon Park; Dong Joo Choi; Hak C Jang; Bo Youn Cho; Young Joo Park
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

Review 10.  A case of Moyamoya disease in a girl with thyrotoxicosis.

Authors:  Ran Lee; Kihye Sung; Yong Mean Park; Jeong Jin Yu; Young-Cho Koh; Sochung Chung
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.